Back to results
US 9,035,072 B2Granted
Process of producing cycloalkylcarboxamido-indole compounds
AssigneeVertex Pharmaceuticals Incorporated
InventorsDaniel T. Belmont, Cristian Harrison, Robert Michael Hughes, Young Chun Jung, Elaine Chungmin Lee, Benjamin Joseph Littler, Peter Jamison Rose, David Andrew Siesel, Gerald J. Tanoury
Life of this patent
Estimating the term…
Abstract
The present invention features processes for preparing compounds, such as (R)-1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide (Compound 1), useful for treating CFTR mediated diseases such as cystic fibrosis.
Claims26
A method for preparing a compound of formula IV:
- wherein, independently for each occurrence:
- ring A is a fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring;
- R1 and R2 is independently selected from —RJ, —ORJ, —N(RJ)2, —NO2, halogen, —CN, —C1-4haloalkyl, —C1-4haloalkoxy, —C(O)N(RJ)2, —NRJC(O)RJ, —SORJ, —SO2RJ, —SO2N(RJ)2, —NRJSO2RJ, —CORJ, —CO2RJ, —NRJSO2N(RJ)2, —COCORJ;
- RJ is hydrogen or C1-6 aliphatic;
- R3 is C1-6 aliphatic optionally substituted with OH, OP, —O—C1-6 aliphatic, aryl, heteroaryl, —O-aryl, or —O-heteroaryl;
- P is a protecting group;
- m is an integer from 0 to 3 inclusive;
- n is an integer from 1 to 4 inclusive;
- and
- o is an integer from 1 to 3 inclusive;
- comprising the steps of:
- a) reacting a compound of formula IIIA:
- wherein, independently for each occurrence:
- R2 is —RJ, —ORJ, —N(RJ)2, —NO2, halogen, —CN, —C1-4haloalkyl, —C1-4haloalkoxy, —C(O)N(RJ)2, —NRJC(O)RJ, —SORJ, —SO2RJ, —SO2N(RJ)2, —NRJSO2RJ, —CORJ, —CO2RJ, —NRJSO2N(RJ)2, —COCORJ;
- RJ is hydrogen or C1-6 aliphatic;
- and
- o is an integer from 0 to 3;
- with a halogenating reagent in a first organic solvent to form a compound of formula IIIB:
- wherein, independently for each occurrence:
- R2 is —RJ, —ORJ, —N(RJ)2, —NO2, halogen, —CN, —C1-4haloalkyl, —C1-4haloalkoxy, —C(O)N(RJ)2, —NRJC(O)RJ, —SORJ, —SO2RJ, —SO2N(RJ)2, —NRJSO2RJ, —CORJ, —CO2RJ, —NRJSO2N(RJ)2, —COCORJ;
- RJ is hydrogen or C1-6 aliphatic;
- o is an integer from 0 to 3;
- and
- Hal is a halide;
- b) reacting the compound of formula IIIB in a second organic solvent with a compound of formula IIIC:
- wherein:
- P is a protecting group;
- followed by reduction and treatment with acid to form a compound of formula IIID:
- wherein:
- R2 is —RJ, —ORJ, —N(RJ)2, —NO2, halogen, —CN, —C1-4haloalkyl, —C1-4haloalkoxy, —C(O)N(RJ)2, —NRJC(O)RJ, —SORJ, —SO2RJ, —SO2N(RJ)2, —NRJSO2 RJ, —CORJ, —CO2RJ, —NRJSO2N(RJ)2, —COCORJ;
- RJ is hydrogen or C1-6 aliphatic;
- o is an integer from 0 to 3;
- Hal is a halide;
- P is a protecting group;
- and
- A ⊖ is an anion;
- c) neutralizing a compound of formula IIID in the presence of a base to form a compound of formula IIID-a:
- wherein:
- R2 is —RJ, —ORJ, —N(RJ)2, —NO2, halogen, —CN, —C1-4haloalkyl, —C1-4haloalkoxy, —C(O)N(RJ)2, —NRJC(O)RJ, —SORJ, —SO2RJ, —SO2N(RJ)2, —NRJSO2RJ, —CO2RJ, —NRJSO2N(RJ)2, —COCORJ;
- RJ is hydrogen or C1-6 aliphatic;
- o is an integer from 0 to 3;
- Hal is a halide;
- and
- P is a protecting group;
- d reacting a compound of formula IIID in a third organic solvent with a compound of formula IIIE:
- wherein, independently for each occurrence:
- R3 is a C1-6 aliphatic optionally substituted with OH, OP, —O—C1-6 aliphatic, aryl, heteroaryl, —O-aryl, or —O-heteroaryl;
- in the presence of a catalyst to form a compound of formula III:
- wherein, independently for each occurrence:
- R2 is —RJ, —ORJ, —N(RJ)2, —NO2, halogen, —CN, —C1-4haloalkyl, —C1-4haloalkoxy, —C(O)N(RJ)2, —NRJC(O)RJ, —SORJ, —SO2RJ, —SO2N(RJ)2, —NRJSO2RJ, —CORJ, —CO2RJ, —NRJSO2N(RJ)2, —COCORJ;
- RJ is hydrogen or C1-6 aliphatic;
- R3 is C1-6 aliphatic optionally substituted with OH, OP, —O—C1-6 aliphatic, aryl, heteroaryl, —O—aryl, or —O-heteroaryl;
- P is a protecting group;
- and
- o is an integer from 0 to 3;
- e reacting the compound of formula III in a fourth organic solvent with a compound of formula II:
- wherein, independently for each occurrence:
- ring A is a fused cycloalkyl, heterocycloalkyl, aryl, or heteroaryl ring;
- Hal is a halide;
- R1 is independently selected from —RJ, —ORJ, —N(RJ)2, —NO2, halogen, —CN, —C1-4haloalkyl, —C1-4haloalkoxy, —C(O)N(RJ)2, —NRJC(O)RJ, —SORJ, —SO2RJ, —SO2N(RJ)2, —NRJSO2RJ, —CORJ, —CO2RJ, —NRJSO2N(RJ)2, —COCORJ;
- RJ is hydrogen or C1-6 aliphatic;
- m is an integer from 0 to 3 inclusive;
- and
- n is an integer from 1 to 4 inclusive;
- to form the compound of formula IV.
62 more elements
A method of preparing Compound 1:
- comprising the steps of:
- a) reacting compound 2:
- with a brominating reagent to form a compound 3:
- b) reacting compound 3 with compound 4:
- followed by reduction to form compound 5:
- followed by neutralizing compound 5 with a base to give compound 5a:
- c) reacting compound 5a with compound 6:
- in the presence of a catalyst to form compound 7:
- d) reacting compound 7 with compound 8:
- to form compound 9:
- and
- e) removing the two Bn protecting groups to form Compound 1.
9 more elements
Dependencies are inferred from the claim text.